Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Expanding Medicaid means fewer colorectal cancer deaths. A study of over 650,000 patients found that living in a Medicaid expansion state was linked to a 6.3% lower risk of death from colorectal cancer. Hispanic patients and those with advanced-stage disease saw the biggest gains, but researchers say every demographic group benefited.
Expanding Medicaid means fewer colorectal cancer deaths — for everyone.
A large study published in JAMA Network Open analyzed more than 658,000 adults diagnosed with colorectal cancer between 2006 and 2021, comparing outcomes in states that expanded Medicaid under the Affordable Care Act versus those that didn't. The verdict? Expansion states had significantly lower overall mortality, with patients facing a 6.3% lower risk of death. Researchers found benefits across all racial groups and all stages of disease.
Hispanic patients stood out as the biggest beneficiaries, with a 22.6% lower risk of death in expansion states. Patients with stage IV (advanced) colorectal cancer also saw an 11.6% mortality reduction — a meaningful finding given how costly and complex their care tends to be.
By the Numbers:
Why it matters: Colorectal cancer is the second deadliest cancer in the U.S., claiming an estimated 55,230 lives this year alone. This study adds to a growing body of evidence — spanning breast, lung, and cervical cancers — that Medicaid expansion saves lives. Researchers warn that rolling back this policy could reverse hard-won survival gains.
